Ameritas Investment Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-26,724
Closed -$2.65M 3097
2019
Q3
$2.65M Sell
26,724
-95
-0.4% -$9.03K 0.12% 166
2019
Q2
$2.48M Buy
26,819
+86
+0.3% +$8.17K 0.11% 183
2019
Q1
$2.52M Buy
26,733
+301
+1% +$26.3K 0.12% 168
2018
Q4
$1.69M Sell
26,432
-5,056
-16% -$373K 0.09% 249
2018
Q3
$2.82M Sell
31,488
-2,561
-8% -$226K 0.13% 157
2018
Q2
$2.7M Sell
34,049
-15,288
-31% -$1.27M 0.13% 154
2018
Q1
$4.4M Sell
49,337
-5,372
-10% -$516K 0.21% 70
2017
Q4
$6.03M Sell
54,709
-3,355
-6% -$379K 0.28% 51
2017
Q3
$8.25M Sell
58,064
-95
-0.2% -$12.9K 0.39% 31
2017
Q2
$7.55M Sell
58,159
-19
-0% -$2.33K 0.37% 33
2017
Q1
$7.24M Sell
58,178
-2,832
-5% -$339K 0.36% 36
2016
Q4
$7.06M Buy
61,010
+6,485
+12% +$722K 0.36% 37
2016
Q3
$5.7M Sell
54,525
-10,403
-16% -$1.13M 0.31% 40
2016
Q2
$6.4M Buy
64,928
+1,710
+3% +$177K 0.42% 38
2016
Q1
$6.33M Buy
63,218
+7,974
+14% +$821K 0.42% 38
2015
Q4
$6.61M Buy
55,244
+26,060
+89% +$3.01M 0.45% 34
2015
Q3
$3.16M Sell
29,184
-80
-0.3% -$9.93K 0.23% 80
2015
Q2
$3.39M Hold
29,264
0.22% 90
2015
Q1
$3.37M Sell
29,264
-287
-1% -$34.3K 0.22% 91
2014
Q4
$3.31M Buy
29,551
+1,391
+5% +$147K 0.23% 94
2014
Q3
$2.67M Sell
28,160
-2,214
-7% -$200K 0.19% 119
2014
Q2
$2.61M Sell
30,374
-1,644
-5% -$125K 0.19% 120
2014
Q1
$2.23M Sell
32,018
-34,214
-52% -$2.71M 0.18% 142
2013
Q4
$5.59M Buy
66,232
+15,922
+32% +$1.26M 0.45% 36
2013
Q3
$3.88M Buy
50,310
+14,990
+42% +$1.05M 0.36% 50
2013
Q2
$2.07M Buy
+35,320
New +$2.13M 0.57% 46

Other funds holding CELG

Ameritas Investment Partners's CELG Position: Q4 2019 in Review

Ameritas Investment Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 26,724 shares — an estimated $2.65M sold.

Ameritas Investment Partners first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $8.25M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Ameritas Investment Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Ameritas Investment Partners sold 26,724 Celgene Corp shares in Q4 2019, an estimated $2.65M.
  • Ameritas Investment Partners first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Ameritas Investment Partners's Celgene Corp position peaked at $8.25M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Ameritas Investment Partners's 13F filing for Q4 2019, filed 13 Feb 2020.